9065TI |
Quaternary Ammonium Neuromuscular Blocking Agents Screen, Tissue |
9122TI |
Bupropion and Metabolite Screen, Tissue |
9129FL |
Carisoprodol and Metabolite Screen, Fluid |
9139FL |
Clonazepam and Metabolite Screen, Fluid |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9146UC |
Ethyl Glucuronide Screen, Umbilical Cord Tissue |
9176FL |
Fentanyl and Metabolite Screen, Fluid |
9176TI |
Fentanyl and Metabolite Screen, Tissue |
9190FL |
Ketoacidosis Screen, Postmortem, Fluid (Forensic) |
9288FL |
Tramadol and Metabolite Screen, Fluid |
9326FL |
Gamma-Hydroxybutyric Acid Screen, Fluid |
9329FL |
Benzodiazepines Panel, Fluid |
9329TI |
Benzodiazepines Panel, Tissue |
9341TI |
Flunitrazepam and Metabolites Screen, Tissue |
9351UC |
Basic Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9352UC |
Expanded Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9356FL |
Cannabinoids Screen, Fluid |